Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

HIV DNA vaccine - Inovio

Next Previous
X
Search
Drug Profile

HIV DNA vaccine - Inovio

Alternative Names: PENNVAX-GP; Pennvax-GP; PENNVAX-GP DNA vaccine - Inovio/NIAID; PENNVAX®-GP HIV immunotherapy

Latest Information Update: 10 Apr 2023

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator University of Pennsylvania
  • Developer Inovio Pharmaceuticals
  • Class AIDS vaccines; DNA vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I/II HIV infections

Most Recent Events

  • 19 Feb 2023 Immunogenicity data from a phase I/II trial in HIV infections presented at the 30th Conference on Retroviruses and Opportunistic Infections (CROI-2023)
  • 12 Feb 2022 Immunogenicity and adverse events data from a phase I/II trial in HIV infections presented at the 29th Conference on Retroviruses and Opportunistic Infections (CROI-2022)
  • 19 May 2021 Inovio Pharmaceuticals in collaboration with National Institute of Allergy and Infectious Diseases and University of California completes phase I/II trials in HIV-1 infections in USA (IM, Injection) (NCT03606213)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top